Paper19935641
The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
Klintman M and 6 others. Mod Pathol, 2010. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer. Papers, record 19935641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19935641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The prognostic value of Ki67 is dependent on estrogen receptor status and histological grade in premenopausal patients with node-negative breast cancer.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Ki-67 Antigen | Major topic |
| Adult | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Kaplan-Meier Estimate | |
| Middle Aged | |
| Premenopause | |
| Prognosis | |
| Receptors, Estrogen | |
| Tissue Array Analysis |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42860544 | Tracking CDK1 Dynamics With a Novel Biosensor Mouse and Clinical Cohorts to Predict CDK4/6 Inhibitor Sensitivity in ER+ Breast Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42860544 | PubMed |
| 42243585 | Clinical and Pathological Characteristics and Prognosis of Breast Cancer During Pregnancy and Postpartum: A Multicenter Retrospective Study. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42243585 | PubMed |
| 42226239 | Breast cancer survival prediction using machine learning and multimodal data for personalized care plan. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42226239 | PubMed |
| 37643366 | Clinical and Pathological Characteristics of Patients With Papillary Thyroid Carcinoma Coexisting With Hashimoto's Thyroiditis: A Retrospective Cohort Study. | Cancer Control | 2023 | https://conductscience.org/library/papers/37643366 | PubMed |
| 37546410 | FGF/FGFR1 system in paired breast tumor-adjacent and tumor tissues, associations with mammographic breast density and tumor characteristics. | Front Oncol | 2023 | https://conductscience.org/library/papers/37546410 | PubMed |
| 33194179 | A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study. | Ann Med Surg (Lond) | 2020 | https://conductscience.org/library/papers/33194179 | PubMed |
| 30646210 | Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk. | JAMA Netw Open | 2019 | https://conductscience.org/library/papers/30646210 | PubMed |
| 29888170 | Anticancer Effects of Dihydroartemisinin on Human Esophageal Cancer Cells In Vivo. | Anal Cell Pathol (Amst) | 2018 | https://conductscience.org/library/papers/29888170 | PubMed |
| 29348868 | Luminal-like HER2-negative stage IA breast cancer: a multicenter retrospective study on long-term outcome with propensity score analysis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29348868 | PubMed |
| 29169398 | Identifying accessible prognostic factors for breast cancer relapse: a case-study on 405 histologically confirmed node-negative patients. | World J Surg Oncol | 2017 | https://conductscience.org/library/papers/29169398 | PubMed |
| 28650989 | Tumor tissue protein signatures reflect histological grade of breast cancer. | PLoS One | 2017 | https://conductscience.org/library/papers/28650989 | PubMed |
| 28298390 | Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer. | J Clin Pathol | 2017 | https://conductscience.org/library/papers/28298390 | PubMed |
| 27703526 | Ki-67 is overexpressed in human laryngeal carcinoma and contributes to the proliferation of HEp2 cells. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27703526 | PubMed |
| 27141101 | GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome. | Mol Cancer Res | 2016 | https://conductscience.org/library/papers/27141101 | PubMed |
| 26916072 | Digital image analysis outperforms manual biomarker assessment in breast cancer. | Mod Pathol | 2016 | https://conductscience.org/library/papers/26916072 | PubMed |
| 26742937 | Ki-67 is a prognostic marker for hormone receptor positive tumors. | Clin Transl Oncol | 2016 | https://conductscience.org/library/papers/26742937 | PubMed |
| 26662799 | Influence of BCL2-938 C>A promoter polymorphism and BCL2 gene expression on the progression of breast cancer. | Tumour Biol | 2016 | https://conductscience.org/library/papers/26662799 | PubMed |
| 25400769 | Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. | Int J Clin Exp Pathol | 2014 | https://conductscience.org/library/papers/25400769 | PubMed |
| 25362932 | Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer. | BMC Cancer | 2014 | https://conductscience.org/library/papers/25362932 | PubMed |
| 24977004 | Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools? | J Thorac Dis | 2014 | https://conductscience.org/library/papers/24977004 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| MKI67 | 4288 | PubTator's text mining | https://conductscience.org/library/genes/4288 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19935641
GET https://conductscience.org/api/papers/v1/19935641/cited_by?page=2